Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher
Source: SeekingAlpha
2026-03-23 09:30:06 ET
Neuronetics, Inc. ( STIM ) could be a turnaround story in 2026. However, this comes with many risks. The company reported mostly positive results for Q4 2025 . This could act as a near-term positive catalyst for the stock....
Read the full article on Seeking Alpha
For further details see:
Neuronetics: Highly Speculative, But Revenue Growth Could Drive The Stock Higher
Neuronetics Inc.
NASDAQ: STIM
STIM Trading
-0.35% G/L:
$1.415 Last:
910,739 Volume:
$1.40 Open:
STIM Latest News
STIM Stock Data
$103,071,313
37,324,827
5.78%
18
N/A
Medical Diagnostics & Screening
Healthcare
US
Malvern
